Reviscon está indicado para el dolor de rodilla en pacientes con osteoartritis (OA) que no responden suficientemente al tratamiento farmacológico y analgésico simples (como el acetaminofeno) (paracetamol).

Reviscon® offers the most comprehensive and complete range of dosage forms and hyaluronic acid concentrations, adapted for different therapeutic needs in osteoarthritis treatment.

Reviscon Mono is an intra-articular injection with high molecular weight sodium hyaluronate to prevent pain and motion limitation for all joints caused by Osteoarthritis. Reviscon Mono contains one of the highest molecular weight sodium hyaluronate …

VSY Biotechnology GmbH is pleased to announce that Health Canada has approved Reviscon Mono 2% (2.4 ml), a single-injection viscoelastic sodium hyaluronate solution designed to prevent pain and motion limitation associated with osteoarthritis in all synovial joints.

Reviscon Mono 2.0% is a viscoelastic sodium hyaluronate solution for intra-articular injection, presented in a 2.4 ml single-use glass syringe. Each milliliter of Reviscon Mono contains 20.0 mg of sodium hyaluronate, alongside sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, and water for injection, meticulously ...

All Reviscon products are intra-articular injections containing high molecular weight sodium hyaluronate to prevent pain and improve motion impairments for all joints caused by osteoarthritis. Reviscon products are biocompatible and designed only for intra-articular use. The hyaluronic acid used is not of animal origin.

Reviscon Mono 2.0% conţine soluţie vâsco-elastică de 2.4 ml pentru injecţii monodoze, cu administrare intra-articulară. Reviscon Mono 2.0% este un produs cu efect analgezic, ameliorând mobilitatea articulară şi alte afecţiuni ale articulaţiilor la pacienţi cu boli degenerative, reumatisme sau în cazul altor modificări ale ...

Reviscon ®, con un peso molecular de 3 MDa, es un hialuronato de sodio de alto peso molecular con cadenas de ingredientes activos más largas, proporcionando características únicas de cohesión energética. Esto se traduce en una mayor absorción de impactos, un alto efecto lubricante y una estabilidad y eficiencia duraderas para el paciente.

Reviscon® offers the most comprehensive and complete range of dosage forms and hyaluronic acid concentrations, adapted for different therapeutic needs in osteoarthritis treatment.

Revsicon IA injections are a treatment for osteoarthritis of the II and III d egrees of the Kellgren Lawrence scale.